← Back to Search

Lung Cancer Patients for Lung Cancer (VALUE Trial)

N/A
Recruiting
Led By Jonathan Spicer, MD, PhD
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from trial start until last patient consented, up to 12 months.
Awards & highlights

VALUE Trial Summary

This trial tests if people undergoing lung surgery can safely go home on the same day, using an improved recovery plan.

Eligible Conditions
  • Lung Cancer
  • Surgery

VALUE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from trial start until last patient consented, up to 12 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and from trial start until last patient consented, up to 12 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse Event Rate
Rate of presentation to the emergency room after surgery
Readmission Rate
+1 more
Secondary outcome measures
Duration of indwelling chest tube catheter
Edmonton Symptom Assessment Scale (ESAS)
Functional Assessment of Cancer Therapy - Lung (FACT-L)
+3 more

VALUE Trial Design

1Treatment groups
Experimental Treatment
Group I: Lung Cancer PatientsExperimental Treatment1 Intervention
Patients with stage I or II primary lung cancer or pulmonary metastasis scheduled to undergo surgery.

Find a Location

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
442 Previous Clinical Trials
159,154 Total Patients Enrolled
Jonathan Spicer, MD, PhDPrincipal InvestigatorMcGill University Health Centre/Research Institute of the McGill University Health Centre
2 Previous Clinical Trials
59 Total Patients Enrolled

Media Library

Lung Cancer Patients Clinical Trial Eligibility Overview. Trial Name: NCT05583916 — N/A
Lung Cancer Research Study Groups: Lung Cancer Patients
Lung Cancer Clinical Trial 2023: Lung Cancer Patients Highlights & Side Effects. Trial Name: NCT05583916 — N/A
Lung Cancer Patients 2023 Treatment Timeline for Medical Study. Trial Name: NCT05583916 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are joining the research endeavor?

"Affirmative. Information hosted on clinicaltrials.gov affirms that this medical trial, first posted on September 7th 2022 and updated most recently October 13th 2022, is actively recruiting for 20 individuals at 1 site."

Answered by AI

Are new volunteers being accepted for this research endeavor?

"Affirmative, clinicaltrials.gov has evidence that this study is currently recruiting individuals. It was posted on September 7th 2022 and modified on October 13th 2022. This research requires 20 people to take part at a single site."

Answered by AI
~8 spots leftby Apr 2025